Entering text into the input field will update the search result below

OptiNose GAAP EPS of -$0.23 beats by $0.03, revenue of $22.51M beats by $0.76M

Mar. 08, 2022 7:14 AM ETOptiNose, Inc. (OPTN)By: Deepa Sarvaiya, SA News Editor
  • OptiNose press release (NASDAQ:OPTN): Q4 GAAP EPS of -$0.23 beats by $0.03.
  • Revenue of $22.51M (+37.3% Y/Y) beats by $0.76M.
  • Shares -7.27% PM.
  • Guidance: XHANCE Net Revenue and Average Net Revenue per Prescription.The Company expects XHANCE net revenues for the full

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About OPTN

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
OptiNose, Inc.
Mind Medicine (MindMed) Inc.
Omeros Corporation
Jushi Holdings Inc.
Milestone Pharmaceuticals Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.